ArticleOncotarget2018

PSMD4 is a novel therapeutic target in chemoresistant colorectal cancer activated by cytoplasmic localization of Nrf2.

Ya-Min Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.